Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
14067 | 795 | 31.4 | 75% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
468 | 3 | GLUCOSINOLATES//BILIRUBIN//HEME OXYGENASE | 24157 |
1434 | 2 | BILIRUBIN//HYPERBILIRUBINEMIA//KERNICTERUS | 7874 |
14067 | 1 | GILBERTS SYNDROME//UGT1A1//UGT1A1 GENE | 795 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | GILBERTS SYNDROME | authKW | 3248538 | 17% | 64% | 132 |
2 | UGT1A1 | authKW | 2144044 | 15% | 45% | 123 |
3 | UGT1A1 GENE | authKW | 1038334 | 4% | 97% | 28 |
4 | CRIGLER NAJJAR SYNDROME | authKW | 917170 | 5% | 60% | 40 |
5 | UGT1A16 | authKW | 463636 | 2% | 93% | 13 |
6 | UGT1A128 | authKW | 375718 | 2% | 65% | 15 |
7 | CRIGLER NAJJAR SYNDROME TYPE II | authKW | 345671 | 1% | 100% | 9 |
8 | IRINOTECAN | authKW | 327913 | 16% | 7% | 130 |
9 | HYPERBILIRUBINEMIA | authKW | 290768 | 9% | 10% | 74 |
10 | UDP GLUCURONOSYLTRANSFERASE 1A1 | authKW | 289523 | 2% | 54% | 14 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Gastroenterology & Hepatology | 2004 | 16% | 0% | 125 |
2 | Pediatrics | 1240 | 14% | 0% | 114 |
3 | Medical Laboratory Technology | 740 | 5% | 0% | 42 |
4 | Oncology | 710 | 17% | 0% | 136 |
5 | Pharmacology & Pharmacy | 555 | 17% | 0% | 139 |
6 | Genetics & Heredity | 422 | 11% | 0% | 86 |
7 | Hematology | 193 | 6% | 0% | 44 |
8 | Medicine, Research & Experimental | 151 | 6% | 0% | 50 |
9 | Medicine, General & Internal | 141 | 8% | 0% | 62 |
10 | Transplantation | 40 | 2% | 0% | 15 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | P ONCOL MED | 76816 | 0% | 100% | 2 |
2 | SOMDETCH PHRA DEBHARATANA MED | 76816 | 0% | 100% | 2 |
3 | DIGEST SURG SURG ONCOL SURG 2 | 51205 | 1% | 33% | 4 |
4 | AFFILIATED JIASU CANC HOSP | 38408 | 0% | 100% | 1 |
5 | AFFILIATED SHUGUANG HOSP | 38408 | 0% | 100% | 1 |
6 | AL AMIRI HOSP MED | 38408 | 0% | 100% | 1 |
7 | BARCELONA U705 | 38408 | 0% | 100% | 1 |
8 | BEIJING CHAOYANG HOSPC ITAL | 38408 | 0% | 100% | 1 |
9 | BURLO GAROFOLO CHILDRENS HOSP | 38408 | 0% | 100% | 1 |
10 | CANCERTEAM EQUIPO INTERDISCIPLINARIO ONCOL | 38408 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMACOGENOMICS JOURNAL | 3925 | 1% | 1% | 9 |
2 | PHARMACOGENOMICS | 3643 | 2% | 1% | 13 |
3 | PHARMACOGENETICS | 3274 | 1% | 1% | 9 |
4 | PHARMACOGENETICS AND GENOMICS | 2154 | 1% | 1% | 8 |
5 | BLOOD CELLS MOLECULES AND DISEASES | 1371 | 1% | 0% | 8 |
6 | JOURNAL OF HUMAN GENETICS | 1333 | 1% | 0% | 9 |
7 | PEDIATRIC RESEARCH | 923 | 2% | 0% | 15 |
8 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 734 | 2% | 0% | 12 |
9 | SEMINARS IN LIVER DISEASE | 706 | 1% | 0% | 5 |
10 | HEPATOLOGY | 704 | 2% | 0% | 15 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GILBERTS SYNDROME | 3248538 | 17% | 64% | 132 | Search GILBERTS+SYNDROME | Search GILBERTS+SYNDROME |
2 | UGT1A1 | 2144044 | 15% | 45% | 123 | Search UGT1A1 | Search UGT1A1 |
3 | UGT1A1 GENE | 1038334 | 4% | 97% | 28 | Search UGT1A1+GENE | Search UGT1A1+GENE |
4 | CRIGLER NAJJAR SYNDROME | 917170 | 5% | 60% | 40 | Search CRIGLER+NAJJAR+SYNDROME | Search CRIGLER+NAJJAR+SYNDROME |
5 | UGT1A16 | 463636 | 2% | 93% | 13 | Search UGT1A16 | Search UGT1A16 |
6 | UGT1A128 | 375718 | 2% | 65% | 15 | Search UGT1A128 | Search UGT1A128 |
7 | CRIGLER NAJJAR SYNDROME TYPE II | 345671 | 1% | 100% | 9 | Search CRIGLER+NAJJAR+SYNDROME+TYPE+II | Search CRIGLER+NAJJAR+SYNDROME+TYPE+II |
8 | IRINOTECAN | 327913 | 16% | 7% | 130 | Search IRINOTECAN | Search IRINOTECAN |
9 | HYPERBILIRUBINEMIA | 290768 | 9% | 10% | 74 | Search HYPERBILIRUBINEMIA | Search HYPERBILIRUBINEMIA |
10 | UDP GLUCURONOSYLTRANSFERASE 1A1 | 289523 | 2% | 54% | 14 | Search UDP+GLUCURONOSYLTRANSFERASE+1A1 | Search UDP+GLUCURONOSYLTRANSFERASE+1A1 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CANU, G , MINUCCI, A , ZUPPI, C , CAPOLUONGO, E , (2013) GILBERT AND CRIGLER NAJJAR SYNDROMES: AN UPDATE OF THE UDP-GLUCURONOSYLTRANSFERASE 1A1 (UGT1A1) GENE MUTATION DATABASE.BLOOD CELLS MOLECULES AND DISEASES. VOL. 50. ISSUE 4. P. 273-280 | 43 | 96% | 24 |
2 | BARTLETT, MG , GOURLEY, GR , (2011) ASSESSMENT OF UGT POLYMORPHISMS AND NEONATAL JAUNDICE.SEMINARS IN PERINATOLOGY. VOL. 35. ISSUE 3. P. 127-133 | 63 | 66% | 8 |
3 | YU, ZB , ZHU, KC , WANG, L , LIU, Y , SUN, JM , (2015) ASSOCIATION OF NEONATAL HYPERBILIRUBINEMIA WITH UGT1A1 GENE POLYMORPHISMS: A META-ANALYSIS.MEDICAL SCIENCE MONITOR. VOL. 21. ISSUE . P. 3104 -3114 | 36 | 88% | 2 |
4 | ETIENNE-GRIMALDI, MC , BOYER, JC , THOMAS, F , QUARANTA, S , PICARD, N , LORIOT, MA , NARJOZ, C , PONCET, D , GAGNIEU, MC , GED, C , ET AL (2015) UGT1A1 GENOTYPE AND IRINOTECAN THERAPY: GENERAL REVIEW AND IMPLEMENTATION IN ROUTINE PRACTICE.FUNDAMENTAL & CLINICAL PHARMACOLOGY. VOL. 29. ISSUE 3. P. 219 -237 | 44 | 65% | 8 |
5 | ATASILP, C , CHANSRIWONG, P , SIRACHAINAN, E , REUNGWETWATTANA, T , CHAMNANPHON, M , PUANGPETCH, A , WONGWAISAYAWAN, S , SUKASEM, C , (2016) CORRELATION OF UGT1A1*28 AND *6 POLYMORPHISMS WITH IRINOTECAN-INDUCED NEUTROPENIA IN THAI COLORECTAL CANCER PATIENTS.DRUG METABOLISM AND PHARMACOKINETICS. VOL. 31. ISSUE 1. P. 90 -94 | 22 | 100% | 3 |
6 | BOYER, JC , ETIENNE-GRIMALDI, MC , THOMAS, F , QUARANTA, S , PICARD, N , LORIOT, MA , PONCET, D , GAGNIEU, MC , GED, C , BROLY, F , ET AL (2014) INTEREST OF UGT1A1 GENOTYPING WITHIN DIGESTIVE CANCERS TREATMENT BY IRINOTECAN.BULLETIN DU CANCER. VOL. 101. ISSUE 6. P. 533 -553 | 35 | 78% | 2 |
7 | XU, CL , TANG, XS , QU, YL , KEYOUMU, S , ZHOU, N , TANG, Y , (2016) UGT1A1 GENE POLYMORPHISM IS ASSOCIATED WITH TOXICITY AND CLINICAL EFFICACY OF IRINOTECAN-BASED CHEMOTHERAPY IN PATIENTS WITH ADVANCED COLORECTAL CANCER.CANCER CHEMOTHERAPY AND PHARMACOLOGY. VOL. 78. ISSUE 1. P. 119 -130 | 28 | 76% | 3 |
8 | LI, MM , WANG, ZH , GUO, J , LIU, J , LI, CZ , LIU, L , SHI, H , LIU, LY , LI, HH , XIE, C , ET AL (2014) CLINICAL SIGNIFICANCE OF UGT1A1 GENE POLYMORPHISMS ON IRINOTECAN-BASED REGIMENS AS THE TREATMENT IN METASTATIC COLORECTAL CANCER.ONCOTARGETS AND THERAPY. VOL. 7. ISSUE . P. 1653 -1661 | 26 | 87% | 12 |
9 | COSTA, E , (2006) HEMATOLOGICALLY IMPORTANT MUTATIONS: BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE GENE MUTATIONS IN GILBERT AND CRIGLER-NAJJAR SYNDROMES.BLOOD CELLS MOLECULES AND DISEASES. VOL. 36. ISSUE 1. P. 77-80 | 29 | 100% | 18 |
10 | LIU, X , CHENG, D , KUANG, Q , LIU, G , XU, W , (2014) ASSOCIATION OF UGT1A1*28 POLYMORPHISMS WITH IRINOTECAN-INDUCED TOXICITIES IN COLORECTAL CANCER: A META-ANALYSIS IN CAUCASIANS.PHARMACOGENOMICS JOURNAL. VOL. 14. ISSUE 2. P. 120-129 | 31 | 62% | 29 |
Classes with closest relation at Level 1 |